title: In brief: trifluridine/tipiracil (Lonsurf) for metastatic colorectal cancer.
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000401:mortality / Q000473:pathology; D004338:Drug Combinations; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009362:Neoplasm Metastasis; D011759:Pyrrolidines; D013939:Thymidine Phosphorylase / Q000037:antagonists & inhibitors / Q000378:metabolism; D013941:Thymine; D016896:Treatment Outcome; D014271:Trifluridine; D014498:Uracil / Q000031:analogs & derivatives
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; D004791:Enzyme Inhibitors; D011759:Pyrrolidines; C000613803:trifluridine tipiracil drug combination; D014498:Uracil; C543750:TYMP protein, human; D013939:Thymidine Phosphorylase; D013941:Thymine; D014271:Trifluridine